Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
50% of cutaneous T-cell lymphoma patients treated with 300mg IV infusion achieved objective response ...
BRISBANE, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email